Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer.
about
Treatment of advanced non small cell lung cancer in routine care: a retrospective analysis of 212 consecutive patients treated in a community based oncology group practiceCyclooxygenase-2 inhibitors for non-small-cell lung cancer: A phase II trial and literature review.A study of weekly docetaxel and carboplatin as first-line chemotherapy for advanced non-small cell lung cancer.Colony-stimulating factor use and impact on febrile neutropenia among patients with newly diagnosed breast, colorectal, or non-small cell lung cancer who were receiving chemotherapy.
P2860
Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Multicenter phase II trial of ...... IV non-small-cell lung cancer.
@en
Multicenter phase II trial of ...... IV non-small-cell lung cancer.
@nl
type
label
Multicenter phase II trial of ...... IV non-small-cell lung cancer.
@en
Multicenter phase II trial of ...... IV non-small-cell lung cancer.
@nl
prefLabel
Multicenter phase II trial of ...... IV non-small-cell lung cancer.
@en
Multicenter phase II trial of ...... IV non-small-cell lung cancer.
@nl
P2093
P356
P1433
P1476
Multicenter phase II trial of ...... IV non-small-cell lung cancer.
@en
P2093
J D Luketich
M J Capozzoli
P304
P356
10.1023/A:1008342116536
P577
2000-06-01T00:00:00Z